Patents by Inventor Mark Ewen

Mark Ewen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5658784
    Abstract: The invention features an isolated nucleic acid hybridizable with the complement of the coding strand nucleic acid sequence presented in SEQ ID NO:1, and encoding a protein that is necessary for adenovirus transformation of a mammalian cell. The encoded protein, p300, cooperates with adenovirus E1A (Early-region 1A) proteins to establish the transformed state.
    Type: Grant
    Filed: April 14, 1994
    Date of Patent: August 19, 1997
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Richard Eckner, Mark Ewen, David Livingston